Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity

FEBS Letters
M A BarradasP Dandona

Abstract

The iron chelators desferrioxamine and 1,2-dimethyl-3-hydroxypyrid-4-one (L1) inhibited human platelet aggregation in vitro as well as thromboxane A2 synthesis and conversion of arachidonate to lipoxygenase-derived products. Non-chelating compounds related to L1 were without effect on cyclooxygenase or lipoxygenase activity. Since both cyclooxygenase and lipoxygenase are iron-containing enzymes, it is suggested that the inhibition of platelet function by these iron chelators may be related to the removal or binding of iron associated with these enzymes. These iron chelators may therefore be of potential therapeutic value as platelet antiaggregatory agents and of possible use in the treatment of atherosclerotic and inflammatory joint diseases.

References

Dec 1, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·P AllainP Simon
Jan 1, 1986·Free Radical Research Communications·G J KontoghiorghesJ Lunec
Feb 20, 1986·The New England Journal of Medicine·R Ross
Sep 1, 1966·Annals of the Rheumatic Diseases·K D Muirden
Sep 25, 1973·Biochimica Et Biophysica Acta·W A HarlandC J Brooks
Jul 23, 1983·Lancet·S C DaviesE R Huehns
Aug 20, 1983·Lancet·G KontoghiorghesE R Huehns

❮ Previous
Next ❯

Citations

Mar 1, 1995·Blood Reviews·G J Kontoghiorghes, E D Weinberg
Dec 19, 2002·Free Radical Biology & Medicine·Denis BlacheNadine Loreau
May 16, 2014·Current Medical Research and Opinion·Massimo GalleraniRoberto Manfredini
Apr 7, 2016·Cellular and Molecular Life Sciences : CMLS·Jennifer Yinuo Cao, Scott J Dixon
Apr 17, 2013·Expert Opinion on Investigational Drugs·Christina N KontoghiorgheGeorge J Kontoghiorghes
Jul 1, 1997·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·B SchröppelU B Brückner
Mar 22, 2000·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·U CalişkanH Koç
Apr 12, 2012·Clinical Medicine Insights. Case Reports·Ramy IbrahimMohammad Zaman
Aug 2, 2019·Platelets·Ngan Thi TranRataya Luechapudiporn
Apr 5, 1996·The Journal of Biological Chemistry·R D AbeysingheJ B Porter
Aug 27, 2018·Journal of Molecular Neuroscience : MN·Jia-Rui WuPeng Lei
Nov 6, 2013·Journal of Internal Medicine·J Y Jeremy, N Shukla
Mar 21, 2018·Oncology Letters·Shihui HaoMin Shi
Jun 27, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·George J KontoghiorghesAnnita Kolnagou
Oct 23, 2019·Therapeutic Advances in Drug Safety·Aqil M DaherShaymaa Kadhim Jasim
Aug 6, 2020·Frontiers in Cellular Neuroscience·Jia-Xin RenYi Yang
Feb 14, 1998·The Journal of Surgical Research·A J MatthewsH Buchwald

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.